Join 1776, Horizon Therapeutics and partners for a panel discussion and reception about innovative approaches to addressing the challenges of research and drug development in rare diseases. With 30 million patients living with a rare disease in the U.S., the panel will also explore how stakeholders in the rare disease community may work together to close the innovation gap and address unmet medical needs for patients.